SORRENTO THERAPEUTICS

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SRNE and buy or sell other stocks, ETFs, and their options commission-free!

About SRNE

Sorrento Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It operates through the Sorrento Therapeutics and Scilex segments. 

CEO
Henry H. Ji, PhD
CEOHenry H. Ji, PhD
Employees
—
Employees—
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1989
Founded1989
Employees
—
Employees—

SRNE Key Statistics

Market cap
716.70K
Market cap716.70K
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
190.53K
Average volume190.53K
High today
$0.002
High today$0.002
Low today
$0.0013
Low today$0.0013
Open price
$0.0014
Open price$0.0014
Volume
495.72K
Volume495.72K
52 Week high
$0.021
52 Week high$0.021
52 Week low
$0.0001
52 Week low$0.0001

People also own

Based on the portfolios of people who own SRNE. This list is generated using Robinhood data, and it’s not a recommendation.
Inovio
Vaxart
iBio
Ocugen, Inc
Nikola
Kartoon Studios
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.